2014
DOI: 10.1016/j.yexcr.2014.08.030
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
51
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 70 publications
(54 citation statements)
references
References 58 publications
3
51
0
Order By: Relevance
“…Amandla demonstrated the beneficial effects of Nrf2-activating agents on kidney injury[26]. Juanjuan Wua also reported that the activation of the PI3K/Akt signaling pathway could increase Nrf2 activity[27]. In this study, the expression of Nrf2 and the activity of the PI3K/Akt signaling pathway were significantly increased in ZWT-treated kidneys compared to those in untreated CIS-injured kidneys.…”
Section: Discussionsupporting
confidence: 49%
“…Amandla demonstrated the beneficial effects of Nrf2-activating agents on kidney injury[26]. Juanjuan Wua also reported that the activation of the PI3K/Akt signaling pathway could increase Nrf2 activity[27]. In this study, the expression of Nrf2 and the activity of the PI3K/Akt signaling pathway were significantly increased in ZWT-treated kidneys compared to those in untreated CIS-injured kidneys.…”
Section: Discussionsupporting
confidence: 49%
“…As seen above for O2°− production and thiols, higher SOD and GPx activities appeared in females due to oestrogenic hormones (Borrás et al, 2010;Wu et al, 2014).…”
Section: Liver Oxidative Statussupporting
confidence: 56%
“…Nrf2 regulates a number of metabolic pathways, including the induction of antioxidant pathways including the glutathione pathway, as well as NADPH production through G6PD , the rate-limiting enzyme in the pentose phosphate pathway (52). Thus, the observed reduction in MRP1, NRF2 and its downstream effector glutathione reductase due to MCAM knockdown suggests that MCAM works in concert with altered Nrf2 activation, a notion that is supported by the observation that activation of the PI3K/AKT pathway promotes Nrf2 activation in other cancer types (53). In the present study, comparison of the proteome of chemoresistant to other SCLC cell lines revealed perturbations in various metabolic pathways, highlighted by dysregulation of mitochondrial function, gluconeogenesis, glycolysis, and the pentose phosphate pathway.…”
Section: Discussionmentioning
confidence: 87%